Literature DB >> 23439374

Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease.

Orlando M Gutiérrez1.   

Abstract

Sodium- and phosphorus-based food additives are among the most commonly consumed nutrients in the world. This is because both have diverse applications in processed food manufacturing, leading to their widespread use by the food industry. Since most foods are naturally low in salt, sodium additives almost completely account for the excessive consumption of sodium throughout the world. Similarly, phosphorus additives represent a major and "hidden" phosphorus load in modern diets. These factors pose a major barrier to successfully lowering sodium or phosphorus intake in patients with CKD. As such, any serious effort to reduce sodium or phosphorus consumption will require reductions in the use of these additives by the food industry. The current regulatory environment governing the use of food additives does not favor this goal, however, in large part because these additives have historically been classified as generally safe for public consumption. To overcome these barriers, coordinated efforts will be needed to demonstrate that high intake of these additives is not safe for public consumption and as such should be subject to greater regulatory scrutiny.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439374      PMCID: PMC3582990          DOI: 10.1053/j.ackd.2012.10.008

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  52 in total

Review 1.  Dietary considerations to prevent loss of bone and renal function.

Authors:  M S Calvo
Journal:  Nutrition       Date:  2000 Jul-Aug       Impact factor: 4.008

2.  SPECIFICATIONS FOR THE IDENTITY AND PURITY OF FOOD ADDITIVES AND THEIR TOXICOLOGICAL EVALUATION: EMULSIFIERS, STABILIZERS, BLEACHING AND MATURING AGENTS.

Authors:  P GEDIGK; W WESSEL
Journal:  World Health Organ Tech Rep Ser       Date:  1964

3.  Hidden phosphorus in popular beverages.

Authors:  Lisa Murphy-Gutekunst
Journal:  Nephrol Nurs J       Date:  2005 Jul-Aug       Impact factor: 0.959

4.  Salt--friend or foe?

Authors:  Eberhard Ritz
Journal:  Nephrol Dial Transplant       Date:  2005-12-29       Impact factor: 5.992

5.  Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

Authors:  Serge L Ferrari; Jean-Philippe Bonjour; René Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

6.  Salt enhances flavour by suppressing bitterness.

Authors:  P A Breslin; G K Beauchamp
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

Review 7.  Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.

Authors:  Pierre Meneton; Xavier Jeunemaitre; Hugh E de Wardener; Graham A MacGregor
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

8.  An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women.

Authors:  M Kärkkäinen; C Lamberg-Allardt
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

Review 9.  The taste for salt in humans.

Authors:  R D Mattes
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

Review 10.  Changing phosphorus content of the U.S. diet: potential for adverse effects on bone.

Authors:  M S Calvo; Y K Park
Journal:  J Nutr       Date:  1996-04       Impact factor: 4.798

View more
  25 in total

Review 1.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

Review 2.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

Review 3.  Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

Review 4.  The Western Diet and Chronic Kidney Disease.

Authors:  Divya Hariharan; Kavitha Vellanki; Holly Kramer
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

5.  Contribution of food additives to sodium and phosphorus content of diets rich in processed foods.

Authors:  Anna Carrigan; Andrew Klinger; Suzanne S Choquette; Alexandra Luzuriaga-McPherson; Emmy K Bell; Betty Darnell; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2014-01       Impact factor: 3.655

6.  Effects of phosphorus and calcium to phosphorus consumption ratio on mineral metabolism and cardiometabolic health.

Authors:  Orlando M Gutiérrez; Anna K Porter; Manjula Viggeswarapu; Joseph L Roberts; George R Beck
Journal:  J Nutr Biochem       Date:  2020-03-19       Impact factor: 6.048

7.  Dietary habits, poverty, and chronic kidney disease in an urban population.

Authors:  Deidra C Crews; Marie Fanelli Kuczmarski; Edgar R Miller; Alan B Zonderman; Michele K Evans; Neil R Powe
Journal:  J Ren Nutr       Date:  2014-09-17       Impact factor: 3.655

8.  Effect of food insecurity on chronic kidney disease in lower-income Americans.

Authors:  Deidra C Crews; Marie Fanelli Kuczmarski; Vanessa Grubbs; Elizabeth Hedgeman; Vahakn B Shahinian; Michele K Evans; Alan B Zonderman; Nilka Rios Burrows; Desmond E Williams; Rajiv Saran; Neil R Powe
Journal:  Am J Nephrol       Date:  2014-01-08       Impact factor: 3.754

9.  Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.

Authors:  Orlando M Gutiérrez; Alexandra Luzuriaga-McPherson; Yiming Lin; Linda C Gilbert; Shin-Woo Ha; George R Beck
Journal:  J Clin Endocrinol Metab       Date:  2015-08-31       Impact factor: 5.958

10.  The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysis.

Authors:  Mihály B Tapolyai; Mária Faludi; Klára Berta; Tibor Szarvas; Zsolt Lengvárszky; Miklos Z Molnar; Neville R Dossabhoy; Tibor Fülöp
Journal:  Int Urol Nephrol       Date:  2016-04-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.